Company / Return on Equity (ROE)
BICYCLE THERAPEUTICS PLC Return on Equity (ROE) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-35.9%
FY2025
5-year range
-48.7% / -19.3%
FY2021-FY2025
Trend
-68.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
BICYCLE THERAPEUTICS PLC reports negative total equity of -35.9% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-35.9% in FY2025 with a 5-year CAGR of +17.5%.
Improved from -48.7% to -35.9% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +5.7pp
- 5-Year Change
- +17.5pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 68.5% year-over-year.
- Peak return on equity (roe) was recorded in FY2021.
- Lowest return on equity (roe) in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.98 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -35.9% | -68.5% |
| FY2024 | -21.3% | +56.3% |
| FY2023 | -48.7% | -17.0% |
| FY2022 | -41.6% | -115.7% |
| FY2021 | -19.3% | +63.9% |
| FY2020 | -53.4% | -62.7% |
| FY2019 | -32.8% | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026